Keyphrases
Receptor Blockade
100%
Antibody-mediated Rejection
100%
Interleukin-6 Receptor (IL-6R)
100%
Tocilizumab
75%
Echocardiographic
50%
Transplant Center
25%
Donor-specific
25%
Effective Therapy
25%
University of Washington
25%
Jewish
25%
Functional Status
25%
Systolic Function
25%
Heart Transplant
25%
Biventricular
25%
Alloantibody
25%
Antibody Production
25%
Therapy Discontinuation
25%
Angiotensin II Type 1 Receptor Antibody
25%
Drug-related Complications
25%
Medicine and Dentistry
Receptor Blocking
100%
Antibody Mediated Rejection
100%
Interleukin 6 Receptor
100%
Heart Antibody
100%
Tocilizumab
75%
Transplantation
25%
Prospective Study
25%
Systolic Function
25%
Heart Graft
25%
Functional Status
25%
Angiotensin
25%
Receptor Antibody
25%
Alloantibody
25%
Antibody Generation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tocilizumab
100%
Interleukin 6 Receptor
100%
Heart Antibody
100%
Prospective Study
33%
Angiotensin
33%
Functional Status
33%
Alloantibody
33%
Receptor Antibody
33%